FREDERICK, Md., Nov. 24, 2008 (GLOBE NEWSWIRE) -- BioElectronics Corp. (Other OTC:BIEL.PK - News), the maker of ActiPatch(tm), the drug free anti-inflammatory patch with an embedded battery operated microchip delivering continuous pulse therapy that revolutionizes the way people heal, today announced that Emerging Growth Research, LLP has issued a Buy recommendation on the company’s shares through a new research report on the company. The report, which places a 12-month target price of $0.20 on the company’s shares, outlines the research firm’s belief that the Company’s sales are aggressively ramping and that positive clinical data is expected over the next few months. The report can be viewed online at http://www.wallstreetreportonline.com.
